Once daily insulin glargine may induce loss of basal insulin action in some patients with type 1 diabetes receiving basal bolus regimens: The need for twice daily glargine?

被引：0
|
作者：
Idampitiya, C
Ward, K
Curtis, C
Fernando, DJS
Idris, I
Thomson, G
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A493 / A493
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics and pharmacodynamics of insulin glargine-insulin glulisine basal-bolus and twice-daily premixed analog insulin in type 1 diabetes mellitus patients during three standardized meals
    Lamos, Elizabeth Mary
    Younk, Lisa M.
    Tate, Donna B.
    Davis, Stephen N.
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2016, 3 : 14 - 20
  • [22] Insulin Glargine Versus Intermediate-Acting Insulin as the Basal Component of Multiple Daily Injection Regimens for Adolescents with Type 1 Diabetes Mellitus
    Chase, H. Peter
    Arslanian, Silva
    White, Neil H.
    Tamborlane, William V.
    JOURNAL OF PEDIATRICS, 2008, 153 (04): : 547 - 553
  • [23] A three-month comparison between multiple daily NPH and once daily glargine insulin administration in intensive replacement of basal insulin in type 1 diabetes mellitus
    Rossetti, P
    Pampanelli, S
    Costa, E
    Torlone, E
    Brunetti, P
    Bolli, GB
    DIABETES, 2002, 51 : A54 - A54
  • [24] Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes mellitus requiring insulin intensification-a randomized phase IV trial: Indian subpopulation analyses
    Prasanna Kumar, K. M.
    Shah, Sanjiv
    Shah, Parag
    Cleall, Simon
    Chen, Steve
    Uppal, Shweta
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2017, 37 (02) : 116 - 123
  • [25] Twice-daily insulin glargine for patients with uncontrolled type 2 diabetes mellitus
    Eledrisi, Mohsen
    Suleiman, Noor Nabeel
    Salameh, Obada
    Hamad, Mohammad Khair
    Rabadi, Omar
    Mohamed, Ahmed
    Al Adawi, Rana
    Salam, Abdul
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2019, 15 : 35 - 36
  • [26] Twice-daily compared with once-daily insulin glargine in people with type 1 diabetes using meal-time insulin aspart
    Ashwell, SG
    Gebbie, J
    Home, PD
    DIABETES, 2005, 54 : A119 - A119
  • [27] Randomised open-label trial of insulin lispro protamin suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients
    Giugliano, D.
    Cleall, S.
    Pontiroli, A. E.
    Koivisto, V.
    DIABETOLOGIA, 2011, 54 : S421 - S422
  • [28] Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart
    Ashwell, S. G.
    Gebbie, J.
    Home, P. D.
    DIABETIC MEDICINE, 2006, 23 (08) : 879 - 886
  • [29] Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis)
    Roussel, Ronan
    d'Emden, Michael C.
    Fisher, Miles
    Javier Ampudia-Blasco, F.
    Stella, Peter
    Bizet, Florence
    Cali, Anna M. G.
    Wysham, Carol H.
    DIABETES OBESITY & METABOLISM, 2018, 20 (02): : 448 - 452
  • [30] A three-month comparison between multiple daily NPH and once daily glargine insulin administration in intensive replacement of basal insulin in Type 1 diabetes mellitus.
    Rossetti, P
    Pampanelli, S
    Costa, E
    Torlone, E
    Brunetti, P
    Bolli, GB
    DIABETOLOGIA, 2002, 45 : A259 - A259
12345